Fundai

Barekat Pharmaceutical Group (BAREKAT) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
BAREKAT
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations75,420-242,06084,2073,012,314254,6511,002,784
Net cash inflow (outflow) from operating activities75,420-242,06084,2073,012,314254,6511,002,784
Cash receipts from sale of property, plant and equipment1,369000336,6660
Cash payments for purchase of property, plant and equipment-2,320-1,3850-4,482-10,398-319
Cash payments for loans granted to others-2,765,018-3,107,724-2,418,024-3,038,266-846,500-986,797
Cash receipts from repayment of facilities granted to others3,319,953--1,400,13279,501450,000
Net cash inflow (outflow) from investing activities553,984---1,642,616-458,018-537,116
Net cash inflow (outflow) before financing activities629,404-1,345,029581,183-736,893-740,561322,625
Cash payments for principal of loans-1,383,870-1,317,335-500,457---
Cash payments for interest on loans-231,154-112,356-182,716---
Cash payments for dividends-9,419-77,283-27,966-1,963,150-439,178-49,074
Net cash inflow (outflow) from financing activities-1,624,4431,289,717-711,1391,245,10884,965-187,149
Net increase (decrease) in cash-995,039-55,312-129,956508,215-655,596135,476
Cash balance at beginning of year1,108,023117,034235,812182,847681,58260,090
Effect of changes in exchange rates6,88065602,1051850
Cash balance at end of year119,86462,378105,856693,16726,171195,566
Non-cash transactions405,03810,181,924112,1329,559,0293,398,429549,197

Reporting periods

42 periods are on file for this report, from the period ending 1393/12/29 to the period ending 1405/06/31.